← back to search

Edward P K Parker

London School of Hygiene & Tropical Medicine · GB
Area of research
Infectious Diseases · Health
Research interest
Research interests include Vaccine Coverage and Hesitancy, SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, and COVID-19 Clinical Research Studies.
h-index
28
citations
2,720
works
119
NIH funding
primary concept
Medicine
email

Recent publications

Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BB
Nature Communications 2025cited by 6position: middledoi
Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis
Reproductive Health 2025cited by 5position: middledoi
Immunogenicity of COVID-19 Vaccines During Pregnancy: A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons
The Pediatric Infectious Disease Journal 2025cited by 3position: middledoi
Safe in Pregnancy and Safe in Children: Global Living Systematic Reviews and Meta-analyses Hub for Emergency Vaccines
The Pediatric Infectious Disease Journal 2025cited by 3position: middledoi
Long-term kidney outcomes after COVID-19: a matched cohort study using the OpenSAFELY platform
The Lancet Regional Health - Europe 2025cited by 2position: middledoi
Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines
Nature Communications 2025cited by 2position: lastdoi
Quantifying maternal vaccination opportunities across gestational age windows: a real-world multi-country, longitudinal study
AJOG Global Reports 2025cited by 2position: middledoi
A global living systematic review and meta-analysis hub of emerging vaccines in pregnancy and childhood
Reproductive Health 2025cited by 2position: middledoi
Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates
PLoS ONE 2025cited by 1position: middledoi
Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK
Lara D. Veeken 2025cited by 0position: middledoi
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)
The Lancet Regional Health - Europe 2024cited by 94position: middledoi
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis
Drug Safety 2024cited by 35position: middledoi
Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
EClinicalMedicine 2024cited by 23position: middledoi
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP
Epidemiology 2024cited by 7position: middledoi
Identifying markers of health-seeking behaviour and healthcare access in UK electronic health records
BMJ Open 2024cited by 5position: middledoi
Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy
Vaccine 2024cited by 5position: middledoi
Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry
BMJ Medicine 2024cited by 4position: middledoi
Quantifying and Adjusting for Confounding From Health-Seeking Behavior and Health Care Access in Observational Research
Open Forum Infectious Diseases 2024cited by 4position: middledoi
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
The Lancet Public Health 2023cited by 97position: middledoi
Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis
Vaccine 2023cited by 84position: middledoi
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP
BMJ 2023cited by 41position: middledoi
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
The Lancet Regional Health - Europe 2023cited by 28position: firstdoi
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking
Nature Communications 2023cited by 10position: middledoi
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases
Clinical Kidney Journal 2023cited by 9position: middledoi
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
BMJ Open 2023cited by 8position: middledoi
Increased bacterial taxonomic and functional diversity is associated with impaired rotavirus vaccine immunogenicity in infants from India and Malawi
BMC Microbiology 2023cited by 6position: lastdoi
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis
Medicine 2023cited by 6position: middledoi
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
EClinicalMedicine 2023cited by 6position: middledoi
CHALLENGES IN ESTIMATING THE EFFECTIVENESS OF 2 DOSES OF COVID-19 VACCINE BEYOND 6 MONTHS IN ENGLAND
American Journal of Epidemiology 2023cited by 5position: middledoi
Association Between Maternal Breastmilk Microbiota Composition and Rotavirus Vaccine Response in African, Asian, and European Infants: A Prospective Cohort Study
The Journal of Infectious Diseases 2023cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Beate Kampmann · Harvard University12 papers (2018–2025)Agustín Ciapponi · London School of Hygiene & Tropical Medicine10 papers (2021–2025)Andy Stergachis · University of Washington10 papers (2021–2025)Pierre Buekens · Tulane University10 papers (2021–2025)Mabel Berrueta · Consejo Nacional de Investigaciones Científicas y Técnicas10 papers (2021–2025) · 10 papers (2021–2025)Xu Xiong · Tulane University10 papers (2021–2025) · 9 papers (2021–2025) · 8 papers (2021–2025)Flor M. Muñoz · Baylor College of Medicine8 papers (2021–2025)William Hulme · Angkor Hospital for Children6 papers (2023–2024)Ben Goldacre · Angkor Hospital for Children6 papers (2023–2024) · 6 papers (2024–2025)Dorothea Nitsch · London School of Hygiene & Tropical Medicine6 papers (2023–2024)Amir Mehrkar · University of Oxford6 papers (2023–2024) · 6 papers (2024–2025)Brian MacKenna · Science Oxford5 papers (2023–2024)Agustina Mazzoni · Tulane University5 papers (2021–2025) · 5 papers (2017–2023) · 5 papers (2024–2025)